Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Nexocin EC 250mg gastro-resistant tablets
1001010P0BYAAAH
|
Nexocin | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Nexocin EC 375mg gastro-resistant tablets
1001010P0BYABAJ
|
Nexocin | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Nexocin EC 500mg gastro-resistant tablets
1001010P0BYACAI
|
Nexocin | Naproxen | Musculoskeletal and Joint Diseases | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.